BRII-179

BIOLOGICAL2 trials

Sponsors

Brii Biosciences Limited

Conditions

Chronic Hepatitis B Virus (HBV) InfectionFor Treatment of Chronic Hepatitis B Virus Infection

Phase 2

Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH)

CompletedNCT06491563

Brii Biosciences LimitedFor Treatment of Chronic Hepatitis B Virus Infection

Start: 2024-08-06End: 2026-08-05Updated: 2026-10-21

A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)

RecruitingNCT06650852

Brii Biosciences LimitedChronic Hepatitis B Virus (HBV) Infection

Start: 2024-10-31End: 2029-09-01Target: 250Updated: 2026-10-22